B12, Taurine, and Cardiovascular Nutrition

Evidence Review

Scallop Protein, Obesity Prevention, and Lipid Improvement

Tastesen et al. (2014, PMID 24658997) conducted a controlled feeding study in male C57BL/6J mice comparing four dietary protein sources (scallop, chicken, casein, and a low-taurine fish protein) under obesogenic high-fat, high-sucrose conditions. The scallop protein group was the only one to completely prevent diet-induced obesity over the study period. At the end of the intervention, scallop-fed animals had significantly lower body fat percentages, lower triglycerides, lower total plasma cholesterol, and a markedly higher HDL-to-total-cholesterol ratio compared to chicken and casein controls.

Taurine intake correlated negatively with body fat accumulation (r = −0.65, p < 0.01). Glycine intake correlated positively with the protective HDL-to-total-cholesterol ratio. EPA and DHA content was similar across the seafood groups and could not account for the differential outcome, supporting the conclusion that the free amino acid composition of scallop protein — particularly its high taurine and glycine — drove the protective effects.

The study is in a mouse model and cannot be directly extrapolated to humans, but the strength of the dose-response relationship and the identified mechanism are clinically plausible given the human taurine literature.

Atherosclerosis Reduction by Scallop and Cod Consumption

Jensen et al. (2016, PMID 26839578) used female apoE-deficient mice, a model prone to aggressive atherosclerosis, to compare scallop-and-cod protein versus chicken protein during 13 weeks on a Western-type high-fat diet. The primary endpoint was quantification of atherosclerotic plaque area in the aorta, assessed by histological analysis of stained sections.

Total aortic plaque burden was reduced by 24% in the seafood group versus chicken controls (p < 0.05). In the aortic sinus and brachiocephalic artery — regions of high clinical relevance due to their proximity to the heart — reductions of 46–56% were observed. Secondary endpoints included plasma lipids (LDL, HDL, total cholesterol), fasting glucose, and leptin. The seafood group showed significantly lower LDL, lower fasting glucose, and lower leptin concentrations.

This study provides direct evidence that substituting scallop protein (alongside cod) for white meat protein produces structural cardiovascular benefits, not merely biomarker changes. The limitation is that the model involves genetically induced hyperlipidemia and a deliberately atherogenic diet, so effect sizes would likely be smaller in a human population without these risk conditions.

Taurine Cardiovascular Meta-Analysis

Tzang et al. (2024, PMID 39148075) conducted a systematic review and meta-analysis of 20 randomized controlled trials enrolling 808 participants to assess cardiovascular effects of taurine supplementation. The pooled analyses found:

• Systolic blood pressure reduced by a mean of 4.07 mmHg (95% CI: −5.26 to −2.88, p < 0.001)
• Resting heart rate reduced by 3.59 bpm (95% CI: −6.13 to −1.05, p = 0.005)
• Left ventricular ejection fraction improved by 5.05% (95% CI: 0.63–9.47, p = 0.025)

Subgroup analyses showed the blood pressure effect was stronger in trials of patients with hypertension or cardiovascular disease than in healthy adults, suggesting a corrective rather than a pharmacological mechanism.

These effects are from isolated taurine supplementation at doses of 1–6 g/day. Dietary taurine from scallops would be at lower doses (perhaps 300–800 mg per serving), but habitual intake across several servings weekly would accumulate meaningfully, particularly for people whose baseline taurine intake from other sources is low.

Omega-3 Content in Pecten Scallops

Su and Babb (2007, PMID 17392140) analyzed the total lipid and long-chain polyunsaturated fatty acid (LC-PUFA) content of Pecten fumatus (Australian bass strait scallops) before and after different cooking methods. Raw scallops contained 312–522 mg of n-3 LC-PUFAs per 100 g, with DHA the predominant fraction. Steaming preserved DHA content most effectively, while high-temperature pan-frying led to greater LC-PUFA degradation.

The omega-3 values in this species are on the lower end of what is found in oily fish like mackerel or herring, but are nutritionally meaningful, particularly given scallops' very low total fat content and the absence of any competing high saturated fat intake. Consuming scallops three times per week could contribute approximately 600–900 mg of EPA + DHA, representing roughly 40–60% of the 1,500 mg weekly intake associated with cardiovascular risk reduction.

Shellfish Comprehensive Nutritional Review

Venugopal and Gopakumar (2017, PMID 33371588) reviewed nutritional composition, health benefits, and safety considerations across shellfish classes including bivalves. The authors confirmed that scallops and other bivalves consistently provide highly digestible protein, EPA and DHA, vitamin B12, selenium, zinc, and choline. Each of these nutrient classes is associated with specific documented health benefits across large epidemiological and intervention databases.

The review also assessed food safety considerations relevant to shellfish consumption: heavy metal accumulation, paralytic shellfish toxins from algal blooms, and microbiological hazards. For commercially sold scallops from regulated sources, these risks are managed within acceptable safety thresholds. The authors recommended consuming scallops and other bivalves as part of a varied diet rather than as a sole protein source.

ACE-Inhibitory Peptides from Scallop Tissue

Gao et al. (2021, PMID 33356234) isolated and characterized five novel ACE-inhibitory peptides from the fermented skirt (mantle) tissue of Chlamys farreri scallops. In spontaneously hypertensive rats, the most active peptide fractions significantly reduced systolic and diastolic blood pressure over a 4-week administration period. Histological analysis showed improved arterial wall structure, with reduced fibrosis and inflammation markers. The study also found that the intervention restored gut microbiota composition toward a healthier profile, including increased relative abundance of Lactobacillus species and decreased abundance of proinflammatory taxa.

This work is mechanistically interesting for demonstrating that scallop-derived compounds can act on the renin-angiotensin system — a major target of antihypertensive medication. The practical application is not clear-cut, since eating the skirt tissue in usual quantities would deliver these peptides in much lower concentrations than the isolated fractions used experimentally. However, the finding adds biological plausibility to the cardiovascular effects observed in whole-diet studies.

Overall Evidence Assessment

The nutritional case for scallops is strong and consistent across independent analyses: they are a low-calorie, high-protein seafood with genuinely notable concentrations of B12, taurine, glycine, selenium, and omega-3s. The metabolic and cardiovascular benefits observed in animal models are mechanistically coherent and supported by a robust human taurine meta-analysis. No human RCT has specifically tested scallop consumption as an intervention, so the magnitude of benefit in humans remains an extrapolation.

Safety considerations are minimal for commercially sold scallops from clean-water sources. The main practical limitation is that scallops are more perishable and expensive than other nutritious shellfish like mussels or oysters.